Business Insurance Lucid Diagnostics Announces First Commercial Insurance Coverage for EsoGuard® Esophageal DNA TestBy insurancejournalnewsMarch 14, 20250 Lucid Diagnostics has achieved a key milestone with its EsoGuard® Esophageal DNA Test securing its first positive commercial insurance coverage through Highmark Blue Cross Blue Shield in New York.
Highmark Blue Cross Blue Shield to Cover Non-Invasive Screening for Esophageal Precancer and CancerBy insurancejournalnewsMarch 14, 20250 Lucid Diagnostics announces positive coverage policy for EsoGuard® test in New York.
